COVID-19 Update: Deadliest Day for U.S.; ‘Apocalyptic’ ER; Kaiser All in on HCQ Hype
by Greg Portz/MedPage Today
Note that some links may require registration or subscription.
Slim ray of hope: With a total case count of 69,197 as of 8:00 a.m. EDT Thursday, the acceleration has slowed a little bit. From last Friday to Monday, newly diagnosed cases more than doubled, but in the last three days, it hasn’t quite doubled yet.
Doctors describe “apocalyptic” ER in New York City, where 13 died of COVID-19 in 24 hours in the same hospital. (ABC7)
It’s an apocalypse for the U.S. economy, too: new unemployment claims hit almost 3.3 million last week, the “highest level of seasonally adjusted initial claims” in history, the Labor Department said Thursday morning.
China reported on Wednesday that there was no local coronavirus transmission, only cases imported from outside of the country. (Reuters)
With this in mind, NIAID Director Anthony Fauci, MD, warned of imported cases after travel restrictions are relaxed in the U.S. (USA Today)
The EU’s Centre for Disease Prevention and Control warns not to expect COVID-19 to wane because of warmer spring weather — noting that “high reproductive numbers were observed” in warm, humid regions such as Singapore and China’s southerly Guangxi province.
And another of the unanswered questions about COVID-19: can survivors become reinfected? The New York Times talks to the experts.
Kaiser Permanente in California appears to have bought into the hydroxychloroquine hype, telling patients taking the drug for lupus they can’t get prescription refills — but thanking them for their “sacrifice.” (BuzzFeed News)
In the COVID-19-era, is modeling still of value? (The Guardian)
A JAMA research letter said reusable elastomeric half-mask respirators were comparable to disposable N95 respirators in terms of fit-testing, but there was no data on use, and “better understanding about the efficacy and feasibility of disinfection methods are key.”
Hospitals in the U.S. are airlifting supplies in from around the world. (KHN)
The COVID-19 pandemic will cost Medicare anywhere from $38.5 billion to $115.4 billion over the next 12 months, depending on a variety of factors, according to the trade group for accountable care organizations.
“Tiptoe back toward normalcy“? Experts talk strategies when it comes to easing up restrictions. (STAT)